Medcath Corp - Current report filing (8-K)
November 14 2007 - 7:32AM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
Date of Report (Date of earliest event reported): November 13, 2007
MEDCATH CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-33009
|
|
56-2248952
|
(State or other jurisdiction of
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
incorporation or organization)
|
|
|
|
|
10720 Sikes Place
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
(704) 708-6600
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c))
Item 2.02. Results of Operations and Financial Condition
On November 13, 2007, MedCath Corporation (MedCath or the Company) issued a press release
announcing the Companys results of operations for the fiscal quarter ended September 30, 2007. A
copy of the press release is furnished as Exhibit 99.1.
Included in the press release and the supplemental financial information issued by the Company and
furnished herewith as Exhibits 99.1 and 99.2, are certain non-GAAP financial measures, including
Adjusted EBITDA. Adjusted EBITDA represents MedCaths income from continuing operations before
interest expense; loss on early extinguishment of debt; income tax expense; depreciation;
amortization; impairment of long-lived assets; share-based compensation expense; loss (gain) on
disposal of property, equipment and other assets; interest and other income, net; equity in net
earnings of unconsolidated affiliates; minority interest share of earnings of consolidated
subsidiaries; and pre-opening expenses. MedCaths management uses Adjusted EBITDA to measure the
performance of the companys various operating entities, to compare actual results to historical
and budgeted results, and to make capital allocation decisions. Management provides Adjusted EBITDA
to investors to assist them in performing their analyses of MedCaths historical operating results.
Further, management believes that many investors in MedCath also invest in, or have knowledge of,
other healthcare companies that use Adjusted EBITDA as a financial performance measure. Because
Adjusted EBITDA is a non-GAAP measure, Adjusted EBITDA, as defined above, may not be comparable to
other similarly titled measures of other companies. MedCath has included a supplemental schedule
with the financial statements that accompanies this press release that reconciles historical
Adjusted EBITDA to MedCaths income from continuing operations.
Item 9.01. Financial Statements and Exhibits
|
|
|
Exhibit 99.1
|
|
Press Release dated November 13, 2007
|
Exhibit 99.2
|
|
Financial Update dated November 13, 2007
|
The exhibits set forth under this Item 9.01 that are being furnished under Item 2.02
shall not be deemed filed for purpose of Section 18 of the Securities Exchange Act of 1934, as
amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act
of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
MEDCATH CORPORATION
|
|
|
|
|
|
Date: November 14, 2007
|
|
By:
|
|
/s/ James E. Harris
James E. Harris
Executive Vice President and Chief Financial Officer
|
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024